Specific classification and new therapeutic targets for neuroendocrine prostate cancer: A patient-based, diagnostic study

Objective: Neuroendocrine prostate cancer (NEPC) is an aggressive variant of prostate cancer (PC) that may arise de novo or in patients previously treated with hormonal therapies for prostate adenocarcinoma as a mechanism of resistance. In our investigation, there appeared to be a strong correlation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, YouZhi, Wu, Ning, Wang, KeKe, Liao, YiHao, Guo, JiaNing, Zhong, BoQiang, Guo, Tao, Liang, JiaMing, Jiang, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479159/
https://www.ncbi.nlm.nih.gov/pubmed/36118857
http://dx.doi.org/10.3389/fgene.2022.955133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479159/
https://www.ncbi.nlm.nih.gov/pubmed/36118857
http://dx.doi.org/10.3389/fgene.2022.955133

Ejemplares similares